Cargando…
Biologics in severe asthma: the role of real-world evidence from registries
Asthma is one of the most common noncommunicable diseases; in the majority of patients it is well controlled with inhaled bronchodilators and inhaled corticosteroids, but the management of severe asthma has been a significant challenge historically. The introduction of novel biologic drugs in the pa...
Autores principales: | Paoletti, Giovanni, Pepys, Jack, Casini, Marta, Di Bona, Danilo, Heffler, Enrico, Goh, Celine Y.Y., Price, David B., Canonica, Giorgio Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489006/ https://www.ncbi.nlm.nih.gov/pubmed/35675922 http://dx.doi.org/10.1183/16000617.0278-2021 |
Ejemplares similares
-
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis
por: Di Bona, Danilo, et al.
Publicado: (2021) -
Biologics and airway remodeling in severe asthma
por: Varricchi, Gilda, et al.
Publicado: (2022) -
Interleukin-5 in the Pathophysiology of Severe Asthma
por: Pelaia, Corrado, et al.
Publicado: (2019) -
Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
por: Puggioni, Francesca, et al.
Publicado: (2020) -
Artificial intelligence processing electronic health records to identify commonalities and comorbidities cluster at Immuno Center Humanitas
por: Morandini, Pierandrea, et al.
Publicado: (2022)